In patients with DCIS, the majority of CD10+ cells also expressed CD44, reflecting a more mesenchymal phenotype, with lower expression of p63 and TCF7, particularly in high-grade DCIS [72]. The gene discussed is CD44; the disease is ductal breast carcinoma in situ.